Kabra Drugs share news, announcements and annual reports
BSE: 524322Pharmaceuticals & BiotechnologySmall Cap
Kabra Drugs Ltd · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1993
Last close ₹16.37up ₹0.65 (4.13%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹15.72.
30 Oct: open ₹15.99, high ₹16.49, low ₹15.67
52-week range of traded prices to 30 Oct 2026
₹15.30Low, 28 Oct 2026₹35.52High, 11 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹39 Cr3,225th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 5.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 28.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 59,920
Kabra Drugs board meetings
198 filed, newest first. Page 4 of 4.
Aug 2020
Jul 2020
3 Jul · Board meeting
Meeting on 9 Jul 2020
Jun 2020
23 Jun · Board meeting
Meeting on 30 Jun 2020: audited results
Mar 2020
Feb 2020
24 Feb · Board meeting
Meeting on 2 Mar 202012 Feb · Board meeting
Meeting on 19 Feb 2020
Jan 2020
31 Jan · Board meeting
Meeting on 5 Feb 202022 Jan · Board meeting
Meeting on 29 Jan 202021 Jan · Board meeting
Meeting on 8 Feb 2020: quarterly results
Oct 2019
16 Oct · Board meeting
Meeting on 8 Nov 2019: quarterly results
Jul 2019
23 Jul · Board meeting
Meeting on 2 Aug 2019: quarterly results
May 2019
17 May · Board meeting
Meeting on 30 May 2019: audited results
Jan 2019
24 Jan · Board meeting
Meeting on 1 Feb 2019: quarterly results
Sep 2018
14 Sep · Board meeting
Aug 2018
14 Aug · Board meeting
Jul 2018
10 Jul · Board meeting
May 2018
30 May · Board meeting
Feb 2018
14 Feb · Board meeting
Dec 2017
14 Dec · Board meeting
Nov 2017
2 Nov · Board meeting
Oct 2017
4 Oct · Board meeting
Sep 2017
14 Sep · Board meeting
Aug 2017
14 Aug · Board meeting
May 2017
Apr 2017
Aug 2016
May 2016
Feb 2016
13 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 13, 2016, inter alia, has taken the following decisions: 1. The Board ....
Oct 2015
15 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 15, 2015, inter alia, has taken the following decisions : 1. The Board ....
Aug 2015
14 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 14, 2015, inter alia has taken the following decisions: 1. The Board has ....
May 2015
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has taken the following decisions: 1. The Board has approved ....
May 2014
23 May · Board meeting
Board of Directors of the Company at its meeting held on May 21, 2014, inter alia, has taken the following decisions: 1. The Board has re-constituted ....